Scotts Miracle-Gro misses Q1 revenue estimates, to sell Hawthorne unit, sets buyback

Reuters
01/28
<a href="https://laohu8.com/S/SMG">Scotts Miracle-Gro</a> misses Q1 revenue estimates, to sell Hawthorne unit, sets buyback

Overview

  • Lawn and garden products firm's fiscal Q1 revenue missed analyst expectations

  • Adjusted EBITDA for fiscal Q1 beat analyst expectations

  • Company announced divestiture of Hawthorne and $500 mln share repurchase program

Outlook

  • Scotts Miracle-Gro reaffirms fiscal 2026 guidance despite Hawthorne divestiture

  • Company expects fiscal 2026 U.S. Consumer net sales low single-digit growth

  • Scotts Miracle-Gro plans share repurchase program to start in late 2026

Result Drivers

  • MARGIN IMPROVEMENT - Co reported gross margin rate improvement by 90 basis points over prior year

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Miss

$354.40 mln

$358.43 mln (7 Analysts)

Q1 EPS

-$2.16

Q1 Net Income

-$125 mln

Q1 Adjusted EBITDA

Beat

$3 mln

-$11.12 mln (6 Analysts)

Q1 Gross Margin

88.70%

Q1 Basic EPS

-$2.16

Q1 Operating Income

-$21.80 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • Wall Street's median 12-month price target for Scotts Miracle-Gro Co is $70.00, about 10.7% above its January 27 closing price of $63.23

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nGNX7SpRm2

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10